FindMyRecallSubscribe
Class I: serious health riskTerminated

The Menz Club V Maxx Rx Recall

V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561

The Menz Club, LLC · Ridgeland, MS

Risk level
Class I
Reported by FDA
Aug 29, 2012
Recall ID
D-1657-2012
Check your lot numberHow we source this data

Summary

The Menz Club recalled V Maxx Rx starting May 25, 2012. The FDA classified it as Class I (serious health risk) and published enforcement report D-1657-2012 on Aug 29, 2012. Reason: Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs.

Product description

V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister pack UPC Code 0972859402; c) 10-count bottle UPC code 0913251017 bottles, Manufactured by The Menz Club, LLC, 103 W. Washington Street, Suite B5, Ridgeland, MS 39157, Phone: 601-866-6746

Lot numbers, UPCs & expiration codes

Lot #s: a) 101108, 101009, 101010, 101011; b) 101108, 101109, 101110; c) 301000, 301001

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1657-2012
Classification
Class I
Status
Terminated
Recall initiated
May 25, 2012
FDA report date
Aug 29, 2012
Quantity
585,000 Capsules
Recall type
Voluntary: Firm initiated
Recalling firm
The Menz Club, LLC

Original FDA data

Every field from FDA enforcement report D-1657-2012, exactly as published.

Show all FDA fields
City
Ridgeland
State
MS
Status
Terminated
Country
United States
Event ID
61957
Address
103 W. Washington Street
Address (line 2)
Suite B5
Code information
Lot #s: a) 101108, 101009, 101010, 101011; b) 101108, 101109, 101110; c) 301000, 301001
Postal code
39157
Report date
Aug 29, 2012
Product type
Drugs
Recall number
D-1657-2012
Classification
Class I
Recalling firm
The Menz Club, LLC
Product quantity
585,000 Capsules
Termination date
Dec 7, 2015
Reason for recall
Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs.
Voluntary / mandated
Voluntary: Firm initiated
Product description
V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister pack UPC Code 0972859402; c) 10-count bottle UPC code 0913251017 bottles, Manufactured by The Menz Club, LLC, 103 W. Washington Street, Suite B5, Ridgeland, MS 39157, Phone: 601-866-6746
Distribution pattern
Nationwide
Recall initiation date
May 25, 2012
Initial firm notification
Press Release
Center classification date
Aug 20, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1657-2012, published Aug 29, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls